We raised another hypothesis that fluoxetine may inhibit RIPK1/RIPK3/MLKL-induced necroptosis of astrocytes in MDD to protect astrocyte injury and to reduce proinflammatory cytokines (such as IL-6 and TNF-α) induced by depression disorder. Here, RIPK1 is linked to major depressive disorder.